Nucleoside antiviral and anti-inflammatory compounds and composi

Details Nucleoside antiviral and anti-inflammatory compounds and composi Nucleoside antiviral and anti-inflammatory compounds and composi

1990-10-12

1992-08-11

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 43, 536 11, 536 184, 536 187, 536 22, 536 23, 536 55, 536117, 536121, A61K 3100, C07H 1900

Patent

active

051378760

ABSTRACT:
The compound having the formula: ##STR1## has antiviral activity, specifically in the prevention or treatment of infection by retroviruses, including HIV, and immunosuppressive activity, either as a compound, pharmaceutically acceptable salt, or a pharmaceutical composition ingredient, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing or treating viral infections and modulating immune responses in vivo are also described.

REFERENCES:
patent: 4148888 (1979-04-01), Cantoni et al.
patent: 4309419 (1982-01-01), Wolberg et al.
patent: 4322411 (1982-03-01), Vinegar et al.
patent: 4690917 (1987-09-01), Knight et al.
J. P. Bader et al., 3-Deazaadenosine, and Inhibitor of Adenosylhamocysteine Hydrolase; Virology 89, 494 (1978).
A. J. Bodner et al., Antiviral Acitivty of 3-Deazaadenosine and . . . , Biochem, and Biophysic. Res. Comm., 98, 476 (1981).
P. A. Bonnet et al., N-Nitro and N-Nitroso derivatives in 5, 6, 7, 8 Tetrahydro . . . , J. Chem. Res., 1984, 28.
P. K. Chaing and G. L. Cantoni, Perturbation of Biochemical Transmethylations . . . , Biochem. Pharmac., 28, 1897 (1979).
P. K. Chaing et al., S-Adenosyl-L-Homocysteine Hydrolase: Analogues of S-Adenosyl . . . , Mol. Pharma., 13, 939 (1977).
M. F. DePompei and W. W. Paudler, The Synthesis and Some Chemical and Spectroscopic Properties, J. Heterocycl. Chem., 12, 861 (1975).
W. C. Luma and J. P. Springer, Novel Condensation of 2,3-Epoxybutanal . . . , J. Org. Chem., 46, 3735 (1981).
T. A. Krenitsky et al., Imidazo [4,5-c]pyridines (3-Deazapurines) and . . . , J. Med. Chem., 29, 138 (1986).
C. Levallois et al., Theophylline-like Properties of Xanthine Analogs, Biochem. Pharmaco., 33, 2253 (1984).
C. Sablayrolles et al., Synthesis of Imidazo [1,2-a] Pyrazine Derivatives . . . , J. Med. Chem., 27 206 (1984).
C. M. Stoltzfus and J. A. Montgomery, Selective Inhibition of Avian . . . , J. Virology 38, 173 (1981).
J. C. Teulade et al., C-3 Hydroxylation of some Imidazo [1,2-a]azines, J. Chem. Res. 1986, 202.
W. Trager et al., Plasmodium Falciparum: Antimalarial Activity . . . , Exp. Parasit., 50, 83 (1980).
B. Veroek et al., Hydrazinolysis of some asolopyrazines, Heterocycles, 4, 943 (1976).
W. E. Coyne, "Nonsteroidal Antiinflammataory Agents", Medicinal Chemistry (ed. A. Burger) p. 953 (Wiley-Interscience).
G. D. Diana et al., "Antiviral Agents", Annual Reports in Medicinal Chemistry, 24, p. 129 (1989).
Mitsuya et al., Japan Sci. Soc. Press Tokyo, Japan pp. 227-288 (1985).
Sandstshi et al., Review article in Drugs, 34, pp. 373-390 (1987).

Affiliated with

Also associated with

Rating

Nucleoside antiviral and anti-inflammatory compounds and composi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleoside antiviral and anti-inflammatory compounds and composi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside antiviral and anti-inflammatory compounds and composi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-346406